A team of researchers has found a quicker and more efficient way to create nucleoside analogs, a type of small molecule that can be used in treatments for everything from cancer to viral diseases.

but the yield of nucleosides reported in most prebiotic syntheses is poor. We have therefore investigated certain aspects of prebiotic nucleoside synthesis.